Veklury Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Remdesivir

Indications/Uses

SARS-CoV-2 infections in patients who do not require O₂ support & are considered to need treatment because of risk factors for disease progression of SARS-CoV-2 infection or w/ pneumonia who are infected w/ SARS-CoV-2.

Click to view Veklury detailed prescribing information

Dosage/Direction for Use

Adult & ped weighing ≥40 kg Single dose of 200 mg IV on day 1 followed by once daily doses of 100 mg IV from day 2. Ped weighing 3.5-<40 kg Single dose 5 mg/kg IV on day 1, followed by 2.5 mg/kg IV from day 2. Treatment duration until day 3; until day 5 for pneumonia infected w/ SARS-CoV-2, administered until day 10 if improvement is not obtained.

Click to view Veklury detailed prescribing information

Contraindications

Hypersensitivity.

Click to view Veklury detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Veklury detailed prescribing information

Special Precautions

Carefully monitor patient's condition for infusion & anaphylactic reactions. Perform renal & liver function tests before & periodically after administration. Immediately discontinue administration & take appropriate measures if any abnormalities are observed. Not recommended for adults, infants, childn & older childn w/ eGFR <30 mL/min/1.73 m² & term newborns (7-28 days) w/ serum creatinine levels ≥1 mg/dL; patients w/ ALT levels ≥5 times the upper limit of normal range. Administer only during pregnancy & breastfeeding when therapeutic benefits outweigh risks.

Click to view Veklury detailed prescribing information

Use In Pregnancy & Lactation

Click to view Veklury detailed prescribing information

Adverse Reactions

Hepatic impairment & hypersensitivity (including infusion reactions & anaphylactic reactions: hypotension, HTN, tachycardia, bradycardia, hypoxia, fever, dyspnea, wheezing, angioedema, rash, nausea, vomiting, diaphoresis & shivering).

Click to view Veklury detailed prescribing information

Drug Interactions

Administer w/ caution when co-administered w/ hydroxychloroquine sulfate or chloroquine.

Click to view Veklury detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Veklury detailed prescribing information

Storage

View Veklury storage conditions for details to ensure optimal shelf-life.

Description

View Veklury description for details of the chemical structure and excipients (inactive components).

Action

View Veklury mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antivirals

ATC Classification

J05AB16 - remdesivir ; Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Veklury powd for conc for soln for infusion 100 mg

Packing/Price

1's

Veklury

remdesivir

Manufacturer:

Gilead Sciences

Distributor:

DCH Auriga - Healthcare

Four Star